Literature DB >> 18553014

Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women.

Rejane S Cavalcante1, Benjamin I Kopelman, Beatriz T Costa-Carvalho.   

Abstract

This study evaluated the vaccination response to Haemophilus influenzae type b (Hib) in malnourished pregnant women (MN), cord blood (CB) and in infants at two and six months of age for comparison with a control group (C). Twenty-eight malnourished pregnant women and 29 pregnant controls were immunized with conjugated Act-HIB(R) in the third trimester of pregnancy. Blood samples were collected from all before the immunization, during labor (post immunization), and from CB. All infants were immunized with Hib vaccine according to normal vaccine schedule and sera were collected at two and six months of age. Antibody levels to polyribosylribitol phosphate (PRP) were similar for both groups. Preimmunization: MN 1.94 microg/mL, C 1.68 microg/mL; post-vaccination: MN 18.53 microg/mL and C 17.55 microg/mL; in CB from MN 14.46 microg/mL and from C 17.04 microg/mL. Infants from MN and C mothers presented respectively at two months: 5.18 microg/mL and 8.60 microg/mL and at six months: MN 3.42 microg/mL and C 2.18 microg/mL. Antibody levels were similar in both groups studied (p = 0.485), however the vertical transmission rate was 14% lower in the MN pregnant group. Levels of antibodies > 0.15 microg/mL were found in all newborns from the MN pregnant group. Pregnant MN presented an immunological response to Hib vaccine similar to group C, however, vertical transmission rate of antibodies to PRP in the MN pregnant group was 14% lower than that in C, suggesting a less efficient passage of antibodies within this group.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18553014     DOI: 10.1590/s1413-86702008000100011

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  9 in total

1.  Parasitic Infections in Pregnancy Decrease Placental Transfer of Antipneumococcus Antibodies.

Authors:  Noah D McKittrick; David M Vu; Indu Malhotra; Charles H King; Francis Mutuku; A Desiree LaBeaud
Journal:  Clin Vaccine Immunol       Date:  2017-06-05

Review 2.  Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children.

Authors:  Zhe Zheng
Journal:  Yale J Biol Med       Date:  2022-06-30

Review 3.  Nutritionally mediated programming of the developing immune system.

Authors:  Amanda C Palmer
Journal:  Adv Nutr       Date:  2011-09-06       Impact factor: 8.701

Review 4.  Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.

Authors:  Stefan Niewiesk
Journal:  Front Immunol       Date:  2014-09-16       Impact factor: 7.561

Review 5.  Factors Affecting the FcRn-Mediated Transplacental Transfer of Antibodies and Implications for Vaccination in Pregnancy.

Authors:  Christopher R Wilcox; Beth Holder; Christine E Jones
Journal:  Front Immunol       Date:  2017-10-13       Impact factor: 7.561

6.  Reduced Transplacental Transfer of Antimalarial Antibodies in Kenyan HIV-Exposed Uninfected Infants.

Authors:  Jessica E Ray; Katherine R Dobbs; Sidney O Ogolla; Ibrahim I Daud; John Vulule; Peter O Sumba; Rosemary Rochford; Arlene E Dent
Journal:  Open Forum Infect Dis       Date:  2019-05-20       Impact factor: 3.835

7.  Efficiency of transplacental transfer of respiratory syncytial virus (RSV) specific antibodies among pregnant women in Kenya.

Authors:  Joyce U Nyiro; Elizabeth Bukusi; Dufton Mwaengo; Amek Nyaguara; Bryan Nyawanda; Nancy Otieno; Godfrey Bigogo; Nickson Murunga; Marc-Alain Widdowson; Jennifer R Verani; Sandra S Chaves; Hope Mwangudza; Calleb Odundo; James A Berkley; D James Nokes; Patrick K Munywoki
Journal:  Wellcome Open Res       Date:  2022-04-01

Review 8.  Biological factors that may impair transplacental transfer of RSV antibodies: Implications for maternal immunization policy and research priorities for low- and middle-income countries.

Authors:  Jessica E Atwell; Chelsea S Lutz; Erin G Sparrow; Daniel R Feikin
Journal:  Vaccine       Date:  2022-06-17       Impact factor: 4.169

9.  Malnutrition and maternal vaccination against typhoid toxin.

Authors:  Durga P Neupane; Changhwan Ahn; Yi-An Yang; Gi Young Lee; Jeongmin Song
Journal:  PLoS Pathog       Date:  2022-08-12       Impact factor: 7.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.